- Report
- July 2023
- 135 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- July 2023
- 67 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- October 2023
- 181 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- March 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,423GBP
- Report
- October 2023
- 145 Pages
Global
From €3027EUR$3,150USD£2,598GBP
- Report
- July 2019
- 280 Pages
Global
From €4323EUR$4,499USD£3,711GBP
- Report
- November 2018
- 147 Pages
Global
From €1321EUR$1,375USD£1,134GBP
€2642EUR$2,750USD£2,268GBP
- Report
- September 2021
- 100 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Report
- August 2022
- 324 Pages
Global
From €5852EUR$6,090USD£5,023GBP
- Report
- December 2023
- 168 Pages
Global
From €5764EUR$5,999USD£4,948GBP
The Opioid Abuse market is a subset of the Addiction Disorders Drugs market, which includes drugs used to treat addiction to substances such as alcohol, opioids, and other drugs. Opioid Abuse drugs are used to treat opioid addiction, which is a growing public health concern in many countries. These drugs are designed to reduce cravings and withdrawal symptoms, and to help individuals maintain abstinence from opioids. Commonly prescribed medications include buprenorphine, methadone, and naltrexone.
In addition to pharmaceuticals, the Opioid Abuse market also includes a range of services and treatments, such as counseling, cognitive behavioral therapy, and residential treatment programs. These services are designed to help individuals manage their addiction and reduce the risk of relapse.
Companies in the Opioid Abuse market include pharmaceutical companies, such as Reckitt Benckiser, Purdue Pharma, and Teva Pharmaceuticals; treatment centers, such as Hazelden Betty Ford and the Caron Foundation; and technology companies, such as Health Recovery Solutions and BioCorRx. Show Less Read more
